Terminal deoxynucletidyl transferase (TdT) is overex-pressed in some cancer types, where it might compete with polμduringthe mutagenic repair of double strand breaks (DSBs) through the non-homologous end joining (NHEJ) pathway. Here we report the discoveryand characterization of pyrrolyl and indolyl diketo acids that specificallytarget TdT and behave as nucleotide-competitive inhibitors. These com-pounds show a selective toxicity toward MOLT-4 compared to HeLa cellsthat correlate well with in vitro selectivity for TdT. The binding site oftwo of these inhibitors was determined by cocrystallization with TdT, ex-plaining why these compounds are competitive inhibitors of the deoxy-nucleotide triphosphate (dNTP). In addition, because of the observeddual localization of the phenyl substituent, these studies open thepossibility of rationally designing more potent compounds
New Nucleotide-Competitive Non-Nucleoside Inhibitors of Terminal 2 Deoxynucleotidyl Transferase: Discovery, Characterization, and 3 Crystal Structure in Complex with the Target
MESSORE, ANTONELLA;
2013-01-01
Abstract
Terminal deoxynucletidyl transferase (TdT) is overex-pressed in some cancer types, where it might compete with polμduringthe mutagenic repair of double strand breaks (DSBs) through the non-homologous end joining (NHEJ) pathway. Here we report the discoveryand characterization of pyrrolyl and indolyl diketo acids that specificallytarget TdT and behave as nucleotide-competitive inhibitors. These com-pounds show a selective toxicity toward MOLT-4 compared to HeLa cellsthat correlate well with in vitro selectivity for TdT. The binding site oftwo of these inhibitors was determined by cocrystallization with TdT, ex-plaining why these compounds are competitive inhibitors of the deoxy-nucleotide triphosphate (dNTP). In addition, because of the observeddual localization of the phenyl substituent, these studies open thepossibility of rationally designing more potent compoundsI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.